Carl Zeiss Meditec AG
Healthcare · EUR · XETRA
Price
€26.48
Cap
€12.18B
Earnings
—
30d Trend
+0.4%
54% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 47×Macro 0.99 (−1%)=47
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Carl Zeiss Meditec AG at 47/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 69/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+4.6%
3 MONTHS
-0.2%
12 MONTHS
-53.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Fundamentals (69) and Quality (68) are the primary strengths. I note that momentum is the weakest area at 13/100 — this warrants monitoring. Historical volatility is elevated at 54%. I classify this as a speculative position — elevated volatility at 54% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.